Trials / Withdrawn
WithdrawnNCT06597786
A Study of Exercise Therapy in People With Solid Tumor Cancer
Neoadjuvant Exercise Therapy in Solid Tumors: A Phase 1b Dose Expansion Trial
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether exercise therapy is an effective and safe treatment that causes few or mild side effects when done before standard surgery for solid tumor cancer. The researchers will also study whether the program is feasible (practical) by tracking how well participants follow the program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise therapy | Patients will receive a study kit which includes a smart watch (for monitoring of mobility / lifestyle patterns), heart rate monitor, blood pressure cuff, scale, and e-tablet. Patients may receive a treadmill to perform exercise therapy sessions. The treadmills and study kits are MSK owned equipment that will be deployed to the patients' homes and returned at the end of the study. |
Timeline
- Start date
- 2024-09-12
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
- First posted
- 2024-09-19
- Last updated
- 2025-03-17
Source: ClinicalTrials.gov record NCT06597786. Inclusion in this directory is not an endorsement.